ArticlePloS one2025

Reducing the effective dosage of flutamide on prostate cancer cell lines through combination with selenium nanoparticles: An in-vitro study.

Iman Menbari Oskouie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.